Vaccine Panel Urges More Protection Against RSV, Meningitis and Chikungunya
By I. Edwards HealthDay Reporter
THURSDAY, April 17, 2025 — A panel of federal health experts on Wednesday recommended expanded vaccine options for several diseases, including respiratory syncytial virus (RSV), meningitis and a mosquito-borne illness called chikungunya.
The panel, known as the Advisory Committee on Immunization Practices (ACIP), makes vaccine use recommendations to the director of the U.S. Centers for Disease Control and Prevention (CDC), The Associated Press reported.
These recommendations are almost always approved. But recent leadership changes at the CDC may complicate next steps.
Acting Director Susan Monarez, who is President Donald Trump's pick to lead the CDC, awaits U.S. Senate confirmation. Until that happens, she has recused herself from regular duties due to federal law regarding vaccines.
According to two CDC officials who spoke anonymously, decisions may now fall to U.S. Health Secretary Robert F. Kennedy Jr., a longtime anti-vaccine activist.
The new recommendations include:
-
Adults aged 50 to 59 with certain health problems, like heart disease, diabetes or chronic obstructive pulmonary disorder should be able to get the RSV shot.
-
A new combination vaccine from GSK was endorsed. It protects against five types of meningococcal bacteria, including one linked to college campus outbreaks about 10 years ago.
-
A second vaccine for chikungunya was recommended for travelers age 12 and older heading to countries with current outbreaks. About 100 to 200 cases of chikungunya are reported each year among U.S. travelers.
-
A safety warning was added to an older chikungunya vaccine that uses a weakened live virus. People 65 and older should discuss the risks with their doctor, especially if they have other health conditions. This follows reports of six older adults developing heart or brain symptoms shortly after getting the shot. The cases are stil being investigated.
Sources
- The Associated Press, April 16, 2025
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted April 2025
Read this next
'Harmless' Virus Might Trigger Parkinson's Disease, Researchers Say
WEDNESDAY, July 9, 2025 — A common virus once thought harmless to humans might be linked to Parkinson’s disease, a new study says. The germ, Human Pegivirus (HPgV)...
CDC Now Recommends RSV Vaccine for Some Adults 50+
MONDAY, July 7, 2025 — Adults as young as 50 may now qualify for an RSV vaccine if they have certain health conditions, according to a quiet update from the U.S. Centers for...
Illinois Reports First West Nile Virus Case of 2025
THURSDAY, June 26, 2025 — Illinois has confirmed its first human case of West Nile virus this year, health officials say. The person, who lives in southern Illinois, was...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.